November 29th Networking Event for all NMD4C Members
The NMD4C are excited to extend an invitation to our members to join us at a Networking Event on November 29th at 2:10pm ET. This event is open to all NMD4C members and is an opportunity to meet and network with fellow colleagues, early-career clinicians and researchers, NMD4C investigators and working group members, and to discuss all things neuromuscular!
In recent times, the sweeping migration of meetings and conferences to online platforms has resulted in fewer opportunities for informal networking and interaction that would normally be far more accessible at the variety of meetings and conferences which are hosted during a regular, in-person calendar year. To address this gap, the NMD4C, with input from our early-career community, has made the decision to host a networking event in Gathertown – a platform that offers attendees the flexibility to join discussions within a group, and in private one-on-one meeting spaces. The NMD4C strives to provide opportunities for our early-career members to meet and network with each other, and to create spaces for open discussion between early-career clinicians and researchers and prominent investigators from a variety of areas within the neuromuscular landscape; these informal discussions are an invaluable resource where collaborations are born, ideas nurtured and future research directions discovered.
The event will take place on Monday, November 29th from 2:10 – 3:00pm ET, during the network’s Annual Investigator Meeting. While the Investigator Meeting is open only to the network investigators and working group members, the networking event is open to all members, and offers the opportunity to network with the NMD4C’s steering committee, investigators, leaders and contributors who will be in attendance.
Register Here!
If you are interested in attending the event, please register at the following link: https://bit.ly/NMD4Cnetworkevent.
If you have any questions about the event, please contact NMD4C communications coordinator James Davis at .
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.